[Form 4] Lineage Cell Therapeutics, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kraft Heinz Company (KHC) – Form 3 insider filing: Newly appointed Vice President & Global Controller Chris Asher has filed his initial statement of beneficial ownership dated 22 June 2025.

• Equity stake: 60,346 common shares held directly and 2,525 shares held indirectly through an IRA.
• Equity incentives: Two fully-vested option lots covering 561 shares at $37.09 (expires 03/01/2031) and 724 shares at $38.68 (expires 03/01/2032).
• Restricted equity detail: Footnotes list 17,487 time-based RSUs and 484 PSUs scheduled to vest between 2026-2029, all included in the direct holding figure.
• Compliance context: The filing establishes Mr. Asher as a Section 16 insider who will now be subject to ongoing reporting of future trades.

The disclosure is routine and does not indicate any new purchase or sale; it simply records existing awards and holdings associated with Asher’s executive appointment.

Positive

• Management alignment: New officer holds approximately 62.9 k shares plus options and RSUs, signalling personal financial stake in KHC’s performance.

Negative

• Immaterial scale: The disclosed holdings are negligible relative to Kraft Heinz’s total shares outstanding and therefore have limited market significance.

Insights

Financial Analyst

TL;DR – Routine insider Form 3; minimal market impact.

This filing formalises Chris Asher’s insider status after assuming the VP & Global Controller role. His direct and indirect holdings amount to roughly 62.9 k shares, worth about mid-single-digit millions at current prices, a modest stake for alignment but immaterial versus KHC’s 1.2 bn shares outstanding. No transaction is reported, and the options disclosed are already fully vested, so there is no immediate dilution or cash inflow implication. Overall, the document is chiefly regulatory with negligible valuation impact.

Corporate Governance Expert

TL;DR – Establishes new officer’s ownership, supports transparency.

From a governance standpoint the Form 3 is positive for disclosure completeness. Asher’s mix of direct shares, RSUs, PSUs and in-the-money options embeds long-term incentives aligned with shareholder interests. However, the quantities are small relative to enterprise size and do not alter insider ownership dynamics. No red flags are evident; signature via power of attorney and timely filing meet SEC requirements. Impact on investor decision-making remains neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Amin Dipti

(Last) (First) (Middle)

C/O LINEAGE CELL THERAPEUTICS

2173 SALK AVENUE, SUITE 200

(Street)

CARLSBAD CA 92008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lineage Cell Therapeutics, Inc. [ LCTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.8977	07/01/2025		A		75,000		(1)	07/01/2035	Common Shares	75,000	$0.00	75,000	D

Explanation of Responses:

1. Will vest and become exercisable on the earlier of July 1, 2026 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer.

	/s/ Alexandra Hernandez, as Attorney-in-Fact	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kraft Heinz (KHC) file on July 2, 2025?

A Form 3 reporting the initial beneficial ownership of VP & Global Controller Chris Asher.

How many Kraft Heinz shares does Chris Asher own?

He directly owns 60,346 common shares and indirectly holds 2,525 shares via an IRA.

What derivative securities were disclosed in the Form 3?

Fully-vested stock options for 561 shares at $37.09 (exp. 03/01/2031) and 724 shares at $38.68 (exp. 03/01/2032).

Does the filing indicate any recent share purchase or sale?

No. The Form 3 only registers existing ownership; it does not reflect new transactions.

Why is a Form 3 important for investors?

It identifies when an individual becomes a Section 16 insider, enabling future monitoring of their trades via Forms 4 and 5.